Ryman Healthcare Limited logo

Ryman Healthcare 2024 ASM Executive Chair Address

AGM31 July 2024RYMHealthcare

Ryman Healthcare 2024 Annual Shareholder Meeting Executive Chair
Address


1 August 2024


SLIDE 1: ANNUAL SHAREHOLDER MEETING (HOLDING PAGE)


SLIDE 2: AGENDA


Good morning everyone and welcome to Ryman Healthcare’s 2024 Annual

Shareholder Meeting.


My name is Dean Hamilton.


I joined the Board in June last year, becoming Chair in August. Following the

resignation of former Group CEO Richard Umbers in April this year, I

transitioned to an Executive Chair role. This is a temporary role until a new

Group CEO is in place.


As Chair, it is my pleasure to welcome all shareholders to the meeting both here

in person, and online.


I would also like to welcome all the Ryman team who have joined us today,

including members of our Senior Executive Team.


Joining me this morning on stage are fellow directors Anthony Leighs, Paula Jeffs,

James Miller, Geoff Cumming, Claire Higgins, Kate Munnings and David Pitman.


Also on stage are Deborah Marris, our Group General Counsel and Company

Secretary and Rob Woodgate, our Group Chief Financial Officer.


For today’s proceedings:


I will provide an overview of the last financial year and an outlook.


Following this we will move to the meeting resolutions, of which we have three.



And then onto general business where you will have the opportunity to ask

questions.


Following the conclusion of the meeting we invite you to join us for refreshments

afterwards.


SLIDE 3: VIRTUAL MEETING INSTRUCTIONS


You will have a chance to ask questions and vote on each of the meeting

resolutions as they are considered.


I will provide further instructions as we move through the meeting.


However, if you encounter any issues, please refer to the virtual portal guide

or you can phone the helpline on 0800 200 220.


You can send through your questions at any time via the online portal by clicking

the link shown here on screen.


I would encourage you to do so as early as possible as this will allow us to answer

these questions at the appropriate time during the meeting.


Voting on the resolutions will be conducted by way of a poll.


For shareholders joining us in person today, you would have validated or been

given your shareholder voting card.


If you are a shareholder and did not register on arrival and wish to vote, please

make your way to the registration desk outside the room and staff from MUFG

Corporate Markets will assist you.


Shareholders joining online will be able to cast a vote using the electronic voting

card received when online registration is validated.


To vote, you will need to click on the “Get a Voting Card” button within the

online meeting platform, which is shown here.


You will be asked to enter your Shareholder or Proxy Number to validate your

voting card.


Voting will remain open until 5 minutes after the conclusion of the meeting.




The Company Secretary has confirmed to me that the Notice of Meeting has

been sent to shareholders and other persons entitled to receive it.


We have not received any apologies.


The Company's constitution prescribes a quorum of shareholders. Based on the

information from the registrar, I can confirm that we have a quorum present.


Proxies have been appointed for the purposes of this meeting in respect of

approximately 417 million shares, representing approximately 61 percent of the

total number of shares.


I’d like to thank shareholders for participating in today’s meeting.


My fellow directors and I will vote all discretionary proxies we have received in

favour of the resolutions as set out in the Notice of Meeting.


As detailed in the Notice of Meeting all directors unanimously support each

resolution.


Our Annual Report for the year ended 31 March has been circulated to

shareholders. This is available online on the investor’s section of our website

and the NZX. Copies are also available in the foyer.


SLIDE 4: EXECUTIVE CHAIR’S ADDRESS


There is no doubt that we are in a period of change as Ryman embarks on getting

fit for the future.


Whilst Ryman continues to set the benchmark for retirement living and quality

of care for our residents, in terms of returns to shareholders we have fallen well

short in recent years. Rest assured, as a Board and management team we are

very focused on improving our financial performance which we believe over time

should be reflected in an improved share price.


As we embark on our new future, we are clear on two things - our residents

remain at the heart of everything we do – because without delighted residents

there is no Ryman - and secondly our villages are the place where we create

value – that is where our assets are, that is where we deliver our services.

Everything else we do is in support of these two guiding principles.




As we highlighted at our recent result, we are refining our strategy and driving

an improvement programme that will place much stronger emphasis on our

financial performance, while maintaining our commitment to purpose-driven

care and exceptional resident experience. We know we need to create a more

sustainable balance between care and financial performance.


We are focusing on three areas for financial improvement:

1. improving the performance of our existing villages;

2. improving the efficiency of our new developments and;

3. creating a sustainable and fit for purpose overhead structure to support our

village and new development activities.


We need to get fit for the future!


I’m looking forward to working with the team, and eventually our new Group

CEO, as we focus intently on restoring our financial performance and with that

our returns to shareholders.


More on these areas later.


SLIDE 5: BOARD OF DIRECTORS


There has been significant change at both Board and management.


Over the past 15 months, three directors have retired from the Board and four

new directors have been appointed, demonstrating our commitment to refresh

our Board membership and bringing new capability and experience to governing

your company.


Of the four new directors, two of those were appointed post the Annual

Shareholder Meeting last year. Both of those directors are therefore up for re-

election today.


Kate Munnings joined the Board on 1 November 2023. Kate brings extensive

commercial healthcare experience from her CEO role at Virtus and COO role

at Ramsay in Australia, where she oversaw the operation of 80 hospitals. Earlier

in her career Kate held senior roles in construction and facilities management.

David Pitman joined the Board on 1 May of this year. He brings strong leadership,

strategic and transformation experience across a range of sectors, including



retirement living in Australia. David has held senior roles at Boston Consulting

Group in Australia and the United States as well as at Stockland Group.

I’m delighted that we have been able to attract two new directors of the quality

of Kate and David.


In addition to these two new Board members, Dr Bernadette Eather has joined

Ryman’s Clinical Governance committee as a Clinical Advisor. Bernadette

started her role on 2 April 2024, replacing Dr David Kerr who retired at 31

March 2024.


Bernadette is a highly regarded clinical governance professional in Australia.

She is the Chief Nurse and Clinical Service Director for Ramsay Health Care,

prior to which she was the NSW Director of Patient Safety at the Clinical

Excellence Commission. She brings valuable external oversight and input to

our clinical governance processes.


We have also made several changes to Board committee memberships and all

of these committees now have new chairs – James chairs Audit, Finance, & Risk,

Paula chairs People, Safety and Remuneration, Kate chairs Clinical Governance

and Anthony chairs Governance & Nominations.


We have also established a temporary Board oversight committee to oversee

my performance during my time as Executive Chair. Paula chairs that as the lead

independent director and is supported by James and Anthony.


2024 will also see the retirement of two directors. Geoff Cumming will be

retiring at the end of today’s meeting. Geoff re-joined the Board in 2018 having

been a substantial shareholder in Ryman since listing in 1999. Geoff has been a

passionate supporter of Ryman for a long period of time and I’m sure will

continue to stay close to the company. On behalf of the Board, Geoff, I would

like to thank you for your significant contribution.


Claire Higgins will be stepping down at the end of the calendar year after 10

years on the Board. Claire stepped into the role of Interim Chair in November

2022 and was instrumental in the capital raise and the subsequent Board renewal.

Claire, whilst it is premature to say farewell, as this will be your last ASM, it is

appropriate to thank you for your contribution particularly over the last 18

months.


There has also been significant change in our senior leadership team over the

last year.




In April 2024, we announced that Group CEO Richard Umbers had resigned. I’d

like to thank Richard for his energy and commitment during his time leading

Ryman.


The search for a new Group CEO is well underway. Our goal, all going well, is

to have someone physically in the seat by the end of this calendar year.


In November 2023 we appointed Rob Woodgate as our new Group Chief

Financial Officer. Rob joined us from Fulton Hogan where he was Group CFO

and has a strong track record as a senior finance leader, bringing a wealth of

experience to the role at an important time for the business.


A number of longstanding employees have left in the last 12 months. I’d like to

take the opportunity to thank them all for their efforts.



SLIDE 6: FINANCIAL PERFORMANCE


Changing our financial performance metrics


Ryman has traditionally used underlying profit as the key measure of its financial

performance. We now believe that there are better indicators of performance

that are also more closely tied to our audited financial accounts. We have turned

our focus to three key financial performance metrics:


1. Cash flow from existing operations;

2. Cash flow from development activity; and

3. Net profit before tax and fair value movements per share.


The first two are cash measures. We believe cash flow, like in any traditional

business, is the most objective measure of performance over time.


Existing operations and new developments have very different performance

drivers and cash flows and we believe are best reported on separately.


The combination of these two measures we term as free cash flow.


Net profit before tax and fair value movements measures the operating

performance of the existing operations. It excludes development activities, the

refinancing gains on Occupation Rights and the unrealised valuation movement



in the portfolio between the start and finish of the year. The latter will fluctuate

year to year and over time and we believe, whilst it is very relevant to the growth

in shareholders’ equity, it is unrealised (as we don’t sell the underlying properties

to residents, we instead grant a right to occupy).


FY24 Financial results


Our financial results for the year ended 31 March 2024 were disappointing on a

number of fronts.


On the positive side, we reported an 18% increase in revenue to $689.9 million,

driven by growth in care, village and deferred management fees primarily as our

new villages continue to mature.


However, the combined impact of impairments and other one-off costs, some

$283.9 million in total, has led to a significant reduction in reported net profit

after tax to $4.8 million against the $257.8 million achieved in FY23.


This result was achieved against a particularly challenging operating environment

with residential property markets subdued and cost inflation impacting all areas

of the business.


We took the necessary decision to reassess the carrying value of our land bank

sites in light of the current economic environment and with a higher hurdle on

whether they could be financially successful new developments. This led to two

sites being deemed unsuitable at Karori and Kohimarama (and these will be put

up for sale in coming months) and two sites that had started but been paused

now written down and brought back into the land bank (at Ringwood and

Takapuna).


Despite these non-cash write-downs, it was pleasing that we achieved an

improvement in cash flow from existing operations to $43.3 million (compared

to -$8.5 million in FY23). Contributing to this was a record number of resale

settlements of occupation rights, which continues to underline the attractiveness

of the Ryman offering.


Ryman achieved an underlying profit of $270.0 million, down 11% on the $301.9

million achieved in the prior year, and within our February 2024 guidance range

of $265–285 million. The reduction in underlying profit on FY23 was primarily a

result of lower margins on new developments which have suffered from higher



costs to complete through construction inflation, the impact of delays and higher

interest costs.


SLIDE 7: CAPITAL MANAGEMENT


We are committed to prudent capital management. The Board made the

decision during the year to suspend dividends. The need to continue to spend

capital to complete committed village buildings and the desire to limit increased

borrowings being key factors behind what I believe to be a logical decision and

in the best interests of shareholders.


As previously communicated the company intends to undertake a further review

of the dividend policy at FY26. Any future dividend policy is expected to be based

on cash flow.


At March 2024, net interest bearing debt was $2.51 billion, up $210 million from

March 2023 however in-line with the position at September 2023. Total funding

headroom at March 2024 was $507.5 million (consisting of undrawn facilities and

cash).


Gearing of 36.2% has increased 3.1 percentage points reflecting both higher debt

and the impact on shareholders equity from valuation movements and

impairments. This sits slightly above our medium-term target of 30–35%.


The financial focus of the Board is to strengthen cash flow outcomes from

existing operations and to release capital from our inflight developments. Over

time, we aim to grow the value of Ryman whilst gradually reducing our net debt

position.


SLIDE 8: DEVELOPMENT PROGRESS


Turning to new developments, during FY24 we completed developments at both

John Flynn in Melbourne and William Sanders in Devonport. These are fabulous

new villages for our residents, with state-of-the-art amenities and a continuum

of care.


We also opened the main building at Deborah Cheetham in Ocean Grove,

welcoming residents into our sixth main building in Australia.



At year end, 10 villages were under active construction, including nine which had

already opened to residents. The current build programme is unusually skewed

to main buildings, of which four are expected to be completed in FY25.


Since year end, I’m pleased to announce that the main buildings at Miriam Corban

and James Wattie have both opened. Our village and regional teams have done

a fantastic job of operationalising these buildings which offer a wide range of

village amenities and are a key part of our value proposition for residents. Care

beds and serviced apartment units will now gradually fill over the next couple of

years with both new residents and existing Ryman residents who transition from

independent to more care-based offerings.


We are very focused on finishing the 10 inflight projects on time and at our

forecast cost which will allow us to repay bank debt as we sell down the

occupancy rights.


We have increased our focus on the efficiency of potential brand new village

developments, with a much stronger lens on expected cash recycling and net

present value. We expect to operate with a smaller land bank than we have been

carrying in the past and with a smaller number of developments underway at any

one time. We need to have the discipline to only start a development when we

know we have the financial capacity to finish it.


At March 2024 we had 5,371 units and beds available for development, including

2,627 at sites currently under active development, and 2,744 at our landbank

sites.



SLIDE 9: SUSTAINABILITY PROGRESS


Ryman is committed to our sustainability journey and decarbonising our

operations. We were pleased to have released our first Sustainability Report in

May this year which showcases progress across three priority areas: climate

change, quality care and Indigenous engagement. This report is available on our

website and I’d encourage you to read it.


During the year we announced that our greenhouse gas emissions targets have

been validated by the Science Based Targets initiative. This achievement has been

reached following Ryman formally setting an emissions reduction target of 42%

for scopes 1 and 2, to be achieved by 2030 relative to a base year of 2021.



We remain committed to reducing our environmental footprint. The

procurement of renewable electricity is a key initiative in our emissions

reduction plan. In 2023 we signed a long-term power purchasing agreement with

Solar Bay, through Mercury Energy. As part of this agreement, during FY24,

Ryman’s New Zealand electricity emissions were offset by renewable energy

certificates, which helped to materially reduce our New Zealand based

emissions.


In addition, in our 2024 Annual Report, we have published our first Climate-

Related Disclosures Report, as required by the New Zealand External Reporting

Board. The Disclosure Report outlines how we are embedding climate

considerations into our business model, as well as the impact our business has

on the climate.


SLIDE 10: RECOGNITION DURING THE YEAR


This year, Ryman celebrated a number of key achievements.


We were proud to open three new villages during the year, welcoming our first

residents into Northwood, here in Christchurch, Patrick Hogan in Cambridge

and Bert Newton in Australia.


In addition, we opened a new care centre at Deborah Cheetham in Melbourne,

finishing the year with 48 operating villages, home to some 14,600 residents.


We continued to be recognised by the industry for delivering great care and by

the community for their trust in our brand. We were proud to be named

Reader’s Digest Most Trusted Brand in aged care and retirement living in New

Zealand for the tenth time.


In addition, we won four awards at the 2024 Asia Pacific Eldercare Innovation

Awards, including ‘Operator of the Year – Ageing in Place’ for the second year

running.


We also continued to play an important role in our local communities, working

with our teams and residents to raise funds for the Fred Hollows Foundation

across New Zealand and Australia, who work tirelessly to put an end to

avoidable blindness. 





SLIDE 11: FIT FOR THE FUTURE


We are committed to improving our financial performance.


As I mentioned earlier, we are focused on three key areas:


Firstly, improving the financial performance of our existing villages. We are

looking at both revenue and cost opportunities. What is the optimal mix of our

deferred management fee, weekly fees and services? On the cost side, how do

we match the operating efficiency of our best performing villages across our

whole portfolio?


Secondly, we need to improve the financial efficiency of our new village

developments. We have been unable to fully recycle our build costs with the

first sell down of Occupation Rights across 14 of our last 16 developments.


Many reasons have driven this including a combination of challenging land sites,

higher construction cost inflation than we anticipated, higher interest rates than

when developments were first started, greater overheads, our own changes to

scope once underway, or significant delays through either covid or financial

prudence.


This has come at a significant cost to shareholders. However, the best thing for

residents and shareholders now is to finish the current 10 developments to our

revised forecasts. I’m confident the team can do this.


In terms of NEW developments, we intend to delay putting any spades in the

ground until we are very confident that the new development can 100% recycle

capital.


Thirdly, we need to re-create a sustainable overhead structure that supports the

villages. We have over the last 8 years seen our support costs grow at a faster

rate than our unit and bed numbers. At Ryman we have to become leaner in

what we do.


All of these three areas are under current review. We know change is necessary

and we will be leaning into this in coming months. We will provide a further

update at our interim result in November.





SLIDE 12: AUDITOR


Ryman released its External Auditor Independence Policy in December 2023

providing guidance on the appointment and independence of the external

auditor. The Policy requires the tendering and formal assessment of the external

auditor at least every 10 years.


The Company’s current auditor, Deloitte, has been Ryman’s auditor since listing

on the NZX in 1999, a total of 25 years.


Deloitte has worked constructively with the Company as its auditor since this

time.


In accordance with the External Auditor Independence Policy, the Company

carried out a tender process overseen by Ryman’s Audit, Finance and Risk

Committee. Following a careful review and consideration of the responses, the

Committee recommended to the Board that PwC Auckland was the most

suitable appointment as the external auditor.


The Board agreed with the recommendation of the Audit, Finance, and Risk

Committee and seeks approval of the shareholders at today’s Annual Meeting

to the appointment of PwC Auckland as auditor for the financial year

commencing 1 April 2024.


The decision to recommend a change of auditor in no way reflects the

performance of Deloitte, or the services that they have provided to Ryman.

Ryman would like to thank Deloitte for the service they’ve given the Company

during their 25-year tenure.



SLIDE 13: AGED CARE FUNDING UNDER PRESSURE


Throughout the year, Ryman continued to advocate for change to the current

aged care funding models in both New Zealand and Australia.


As the ageing population expands and longevity increases, more older people

are occupying hospital beds and require care, putting huge pressure on

healthcare systems. As highlighted in the first phase of a Te Whata Ora Health

New Zealand commissioned review, the sector is facing unprecedented

challenges and financial pressures, leading to bed closures by some operators

and limited new builds despite growing demand.




Despite this independent review in their hands, Te Whata Ora, with limited

consultation, has provided only a 3.2% increase in funding for the sector for the

current year and said that they will provide financial support to weaker

operators on a case by case basis. We at Ryman don’t believe that is the right

answer. We question what measure of sustainability, let alone incentive for

growth, does that provide the broader sector which has some 37,000 care beds

– two thirds of which are in private or charitable hands.


We need Governments to acknowledge the crucial role the retirement living

sector has to play in meeting the housing and health needs of the growing

number of older people in both countries.


We believe the government needs to change the funding mechanism rather than

tinkering at the edges.


At Ryman, we believe that New Zealanders deserve to have a choice in the

products and services they receive as they age.


If it’s not fixed, aged care will inevitably become a broader healthcare issue.

Instead of paying $250/night to aged care providers, Te Whata Ora will be paying

$1,400 a night for a public hospital bed and blocking those beds from the general

public.


We’re optimistic that the new coalition Government will see the bigger picture

and create positive change to enable sustainable and equitable access.


In Australia, Ryman has been actively engaging with the Government on key

industry issues. It provided a submission to the Aged Care Task Force, which

subsequently provided recommendations to the Government in March 2024,

including support for a co-contribution model. We are hopeful of bi-partisan

support being reached in current negotiations. The changes proposed will be a

positive sign for the industry and make investing in new aged care assets in

Australia potentially more attractive than in NZ.









SLIDE 14: FY25 OUTLOOK


Looking ahead.


Current economic conditions remain challenging in both New Zealand and

Victoria, and it is unclear when interest rates will begin to decline and support

improved housing market conditions and liquidity.


Incoming residents to independent retirement living in most cases need to sell

their home to fund the Occupation Right upon entry - and as a result residential

market conditions have an impact on timing and affordability for potential new

residents. Most market commentators are expecting tough housing market

conditions to continue for the balance of calendar 2024.


At Ryman we can do little about those external factors, however we do need to

be focused on improving our own performance. There continues to be demand

for living in a Ryman village, as evidenced by strong demand for our independent

living units (noting that we achieved over 1,500 ORA sales in the last financial

year), our high care bed occupancy at our mature villages and the growing

occupancy at our new care facilities.


We are assuming that tough housing market conditions will continue for the

balance of our financial year.


In my mind, market conditions simply reinforce our need to get fit for the future.

Our guidance for the full year remains unchanged:


- To be cash flow positive

- To build 850-950 retirement village units and aged care beds

- To spend between $700-$820 million on capex


Your Board is positive about the future of Ryman. We are energised by the need

for change and are committed to improving Ryman’s financial performance whilst

at the same time maintaining great care and experience for our residents.


Thank you for your time.






SLIDE 15: RESOLUTIONS


Before we move to general business and your opportunity to ask any questions,

we will now move to the formal meeting resolutions which were outlined in the

Notice of Meeting.


Each resolution set out in the Notice of Meeting is to be considered as an

ordinary resolution and, as such, must be approved by a simple majority of the

votes cast by shareholders entitled to vote and voting on the resolution.


A poll will be held on each of today’s three resolutions.


For those of you here today, you will be voting using your voting card. Please

mark your voting intention for each resolution and the voting cards will be

collected at the conclusion of the meeting.


If you require assistance with this, please see MUFG outside the room.


For those of you voting online, you will need to click “Get Voting Card” within

the online meeting platform.


Please mark your electronic voting card in the way you wish to vote by clicking

“FOR”, “AGAINST” or "ABSTAIN".


Once you have made your selection please click “Submit Vote” on the bottom

of the card to lodge your vote.


Please refer to the virtual meeting online portal guide or use the help line

specified if you require assistance.


A quick reminder that voting will remain open until 5 minutes after the

conclusion of the meeting.


Results of the vote will be announced via the NZX.


The outcome of proxy votes received prior to the meeting, will be displayed for

your information after voting on all the resolutions.

There will be an opportunity for shareholders to ask questions on each matter

being put to shareholders. For the sake of good order, shareholders questions



raised should relate directly to the matter being considered. There will be a tine

later to ask general questions.


When I call for questions, can shareholders present in the room please wait until

a microphone is provided to you and clearly state your name.


I will take questions from those present in the meeting first before moving onto

any questions from shareholders online.


I ask that in the interest of fairness to all shareholders attending this meeting,

that anyone wishing to ask questions be as concise as possible and be

considerate of other shareholders wishing to ask questions.


SLIDE 16: RESOLUTION 1 – AUDITOR’S APPOINTMENT &

REMUNERATION


Turning to resolution 1...


Pursuant to section 207P(2) of the Companies Act 1993 the Board seeks

approval of the shareholders to the appointment of PwC Auckland as the auditor

of the Company and pursuant to section 207S of the Companies Act 1993 to

authorise the Board to fix the auditor’s remuneration for the ensuing year.


The Board unanimously supports the appointment of PwC Auckland as the

external auditor.


Are there any questions of the Board concerning the resolution from

shareholders in the room?


Are there any questions online?


I now propose that PwC Auckland is appointed as auditor of the Company and

that the Board is authorised to fix the auditor’s remuneration for the ensuing

year.


Please mark your voting cards in the way you wish to vote by ticking “FOR”,

“AGAINST” or "ABSTAIN" in the appropriate place on the voting card.






SLIDE 17: RESOLUTION 2 – RE-ELECTION OF KATE MUNNINGS


Turning to resolution 2...


Under NZX Listing Rule 2.7.1 a director appointed by the Board must not hold

office (without re-election) past the next Annual Meeting following the director’s

appointment. Kate Munnings was appointed as a non-executive director by the

Board with effect from 1 November 2023. Kate accordingly retires and offers

herself for re-election. Kate is considered by the Board to be independent. The

Board unanimously supports the re-election of Kate.


Kate accordingly retires and offers herself for re-election. She will now

introduce herself.


[Kate]


Good morning, my name is Kate Munnings. I joined the Ryman Healthcare Board

in November 2023, and today seek your support for re-election.


Ryman Healthcare is an iconic New Zealand company and I am honoured to

have an opportunity to serve you on the company’s Board. Thank you for the

opportunity to share what I hope to bring to the Ryman Board and the wider

Ryman family.


My career has been quite diverse, but I think it marries nicely with the needs of

Ryman, at this stage of the company’s history.


I started my career, many years ago, as an assistant in nursing, and spent 3 years

working in aged care. I generally worked night duty because I was training to be

an RN, so I spent many nights talking with residents about their lives and

experiences, as well as providing residents and their families nursing care and

support. So I bring to Ryman front line experience in caring for residents, and I

have a deep understanding of how important that responsibility is for a company

like Ryman.


I then became an RN and specialised in HIV/AIDS nursing. AIDS patients in the

80’s were ostracised and isolated, often for reasons that had nothing to do with

their disease. That experience, led me to study law and I left one of the most

loved professions and joined one of the least loved, when I became a solicitor in

the early 90’s.



I spent 12 years in private legal practice, specialising in construction law. I

progressed to partner and had a leadership role in the construction practice at

the international law firm Baker McKenzie. I spent those years in private practice,

solving complex legal and commercial problems for my clients. So, I bring to

Ryman an understanding of legal issues in the property and construction sector,

as well as experience in solving the complex legal problems.


I then left private practice and spent 8 years at ASX listed Transfield Services as

their Chief Risk & Legal Officer and Company secretary, doing extensive

international M&A and corporate governance advisory work, across Australia,

NZ, US, Canada, Chile and UAE. This was a dramatic change, as in that role, I

was a corporate lawyer, advising an ASX listed board on their responsibilities as

directors; developing and managing an enterprise risk management program and

running large international acquisitions. So I bring to Ryman an understanding of

corporate law, risk management and corporate governance.


When I eventually moved into an operations role, I was responsible for

Transfield Services construction, logistics and consulting businesses across

Australia and NZ. This included providing facilities management in complex

environments such as social housing, schools and defence bases. My business

unit was also responsible for rolling out the NBN in Australia and the fibre

rollout for Enable in Christchurch. So, I bring to Ryman operational experience

in running a facilities management and logistics business in sensitive

environments, as well as experience in running a construction business which

included a large infrastructure project in Christchurch.


After about 23 years working outside of healthcare, I return to the sector about

10 years ago. Since then, I have been running large health care organisations, first

as COO at Ramsay Health Care and then as CEO of Virtus Health Care. So, I

bring to Ryman operational and leadership experience in running large, complex

health services, where I was required to balance the need to provide exceptional

patient care, with sustainable commercial performance.


Importantly, I have also led a number of transformation programmes. They

include a significant transformation programme across Ramsay’s hospital

network - where I was responsible for 73 public and private hospitals; another

programme across 46 ART clinics that spanned 5 countries; and I also guided a

transformation programme from a board role across 8 hospitals and multiple

primary health networks at South East Sydney Local Health District. So, I bring

to Ryman experience in delivering results from transformation programs in large

complex healthcare environments.



My experience also includes delivering impact from a governance role. I have

previously been a director of South-Eastern Sydney Local Health District and

Ramsay Hospital Research Foundation. I currently Chair the Digital Health CRC,

and from today, a few weeks ago, it was announced that I have been appointed

to the Board of Wesfarmers Limited, an iconic company with operations across

Australia and New Zealand. So, I bring to Ryman governance experience as a

director of large and complex organisations.


I commit to you, that I will bring all that I have learned over my career to the

Ryman Board; I will help to support and guide the Ryman team and I will work

extremely hard to ensure that Ryman delivers on its ambition of providing

exceptional care to residents; and exceptional returns to shareholders.


[Dean]


Thank you, Kate...


Are there any questions for Kate or the Board concerning this resolution from

shareholders in the room?


Are there any questions online?


I now propose that Kate Munnings be re-elected a director of the company.


Thank you – please mark your voting cards in the way you wish to vote by ticking

“FOR”, “AGAINST” or "ABSTAIN" in the appropriate place on the voting card.



SLIDE 18: RESOLUTION 3 – RE-ELECTION OF DAVID PITMAN


Now turning to resolution 3...


Under NZX Listing Rule 2.7.1 a director appointed by the Board must not hold

office (without re-election) past the next Annual Meeting following the director’s

appointment. David Pitman was appointed as a non-executive director by the

Board with effect from 1 May 2024. David accordingly retires and offers himself

for re-election at the 2024 Annual Meeting. David is considered by the Board to

be independent. The Board unanimously supports the re-election of David.


David accordingly retires and offers himself for re-election. He will now

introduce himself.





[David]


Thank you Dean.


Good morning. My name is David Pitman; I joined the Ryman Board on 1 May

2024 and today I seek your support for re-election.

As this is my first time before you, it seems appropriate to give you a sense of

my background.


I have accumulated 40 years’ experience in general, operational and financial

management, strategy development and M&A in Executive and Consulting roles.

My undergraduate training was at the University of Sydney where I earned a

Bachelor of Aeronautical Engineering, which led to a nine-year career in the

aviation sector, holding commercial management roles in Sydney and Los

Angeles with responsibilities for aircraft maintenance and product support

businesses.


Wishing to broaden my career, I undertook an MBA at the University of NSW,

from which I was chosen to attend the Wharton School in Philadelphia on

exchange. Upon completing my degree, I joined the Boston Consulting Group,

where I remained for 12 years advising on a diverse range of issues from

competitive strategy through to transformation across many industrial sectors

including financial services, industrial goods, airlines, forestry and consumer

products. I served clients in Australia and New Zealand and also in the USA,

being based in Los Angeles again for a period of time.


I became a Partner of the Global firm in 2003 and, having developed an expertise

in shareholder value management, I was chosen to lead the Corporate Finance

and Strategy practice in the Asia Pacific region.


In 2007, I transitioned to Stockland Corporation as EGM Strategy and Corporate

Development, later assuming the role of CEO of Stockland’s Retirement Living

division.


In that role, I led a transformation of the Retirement business, growing the

portfolio from 24 Melbourne-focused villages to a national network of 62 villages

through a combination of organic development and acquisition. Cash profitability

was restored and grown in both established operations and in new village

development and the culture of the organisation became more performance-



oriented, while retaining high levels of resident satisfaction and employee

engagement, outperforming the relevant external benchmarks.


After more than six years at Stockland, I returned to BCG as a Partner again,

this time in Boston, Massachusetts, as Global Finance Director, overseeing the

firm’s finance operations, accounting and control across 50 countries. I

subsequently relocated back to Sydney in 2018 with my family, assuming a senior

advisor role at BCG before moving into private consulting.


I am excited to have the opportunity to be involved with Ryman, a business

which has earned a reputation for outstanding resident care and high-quality

villages. The business is now undergoing a transformation and, as one of your

representatives on the Board, I can say I am personally committed to seeing that

we maintain our record of great Care while driving a material improvement in

shareholder value.


If elected today, I look forward to leveraging my experience in finance, strategy,

property and retirement living to help achieve that goal.


I would appreciate your support to be re-elected as a Director of Ryman.




[Dean]


Thank you, David...


Are there any questions for David or the Board concerning this resolution from

shareholders in the room?


Are there any questions online?


I now propose that David Pitman be re-elected a director of the company.


Thank you – please mark your voting cards in the way you wish to vote by ticking

“FOR”, “AGAINST” or "ABSTAIN" in the appropriate place on the voting card.





SLIDE 19: GENERAL BUSINESS


I would now like to give shareholders the opportunity to ask questions - whether

related to the presentations, the Financial Statements, or the management of the

company. We will do our best to answer these.


Shareholders online can continue to provide questions through the portal, and

we will also address questions from the room.


If you are asking a question from the floor please state your name, whether you

are a shareholder, or if a proxy holder, the name of the shareholder represented.


Please wait until we bring a microphone to you – so that the people in the room

as well as online can hear you clearly.


Do we have any questions in the room?


Do we have any questions online?



SLIDE 20: THANK YOU


We are now nearing the end of today’s meeting.


In looking ahead, 2024 is a significant year for Ryman marking our 40th

anniversary since opening our first village in New Zealand, our 10-year

anniversary since opening our first village in Victoria, and our 25th anniversary

of being listed on the NZX.


We have an exciting future ahead. Over the next 30 years, New Zealand's

population of seniors aged 65+ will grow from around 850,000 to around 1.5

million. In Australia, by 2066, it is projected that older people will make up

around 23% of the total population.


Ryman is well placed to benefit from this ongoing demographic change. We have

an industry-leading reputation in retirement living and care. We have scale with

48 operating villages across New Zealand and Victoria.



We have over 14,600 residents and a high satisfaction rating by our residents of

their Ryman experience. Importantly, we have a strong sense of purpose

amongst our 7,700 team members.


The next 12 months will be challenging however the business is here for the

long-term. We need to make the changes now so that when conditions improve

we are much fitter and much better placed to capitalise.


Before I close the meeting I would like to acknowledge and thank our people

and teams. You make our culture unique and are integral to the success of our

business. It is your hard work and dedication that ensures our residents have a

great experience.


I would also like to say a very special thank you to our shareholders. We’re

grateful for your on-going support and your confidence in our capacity to deliver

in the future.


I would like to thank my fellow directors who I know are all very focused on

improving the financial performance of your company.


We are committed to balancing care with commerciality. We know we need to

improve the profitability of our operations and the efficiency of our new

developments. We are very focused on getting Ryman fit for the future.


Now, I invite you all to join us for refreshments and an opportunity to catch up.

We have our senior leadership team here as well and so please take the

opportunity to introduce yourself to directors and management. For

shareholders in the room, please pass your voting cards to MUFG Corporate

Markets representatives as you exit.


Thank you.


End of Meeting



Contacts:

For investor relations information contact Hayden Strickett, Head of Investor Relations, on

027 303 1132 (+64 27 303 1132) or email hayden.strickett@rymanhealthcare.com.


For media information or images contact Silke Marsh, Group Corporate Affairs Manager, on

027 294 3609 (+64 27 294 3609) or email silke.marsh@rymanhealthcare.com.

---

R Y M A N H E A L T H C A R E
Annual Shareholder

Meeting

1 August 2024

R Y M A N H E A L T H C A R E |2024 Annual Shareholder Meeting2
Keith Park Village resident Mary and her grandson.

Agenda

2

Welcome and introductions

Executive Chair’s address

Resolutions

General business

R Y M A N H E A L T H C A R E|2024 Annual Shareholder Meeting3
Virtual meeting instructions

R Y M A N H E A L T H C A R E | 2024 Result Presentation4
Deborah Cheetham Village.

4

Executive Chair’s

address

R Y M A N H E A L T H C A R E|2024 Annual Shareholder Meeting5
Retiring in 2024

Elected at 2023 ASM

Up for re-election at 2024 ASM

Board of directors

Elected in prior years

Geoffrey Cumming

NON-EXECUTIVE

DIRECTOR

Joined 2018

Claire Higgins

NON-EXECUTIVE

DIRECTOR

Joined 2014

Dean Hamilton

EXECUTIVE

CHAIR

Joined 2023

James Miller

NON-EXECUTIVE

DIRECTOR

Joined 2023

Kate Munnings

NON-EXECUTIVE

DIRECTOR

Joined 2023

David Pitman

NON-EXECUTIVE

DIRECTOR

Joined 2024

Anthony Leighs

NON-EXECUTIVE

DIRECTOR

Joined 2018

Paula Jeffs

LEAD INDEPENDENT

DIRECTOR

Joined 2019

R Y M A N H E A L T H C A R E|2024 Annual Shareholder Meeting6
FY24 financial performance

Cash flow from

development activity

1

($230.2m)

Up $150.8m | FY23: ($381.0m)

Net profit after tax

(NPAT)

$4.8m

Down 98% | FY23: $257.8m

Cash flow from existing

operations

1

$43.3m

Up $51.8m | FY23: -$8.5m

IFRS profit before tax and fair

value movements (PBTF)

($324.5m)

Down -$99.2m | FY23: ($225.3m)

Per share: (47.2cps) | FY23: (43.6cps)

Total one-off costs

1

($283.9m)

FY23: ($175.4m)

1Cash flow from existing operations, cash flow from development activity, free cash flow and one-off costs are non-GAAP (Generally Accepted Accounting Principles) measures and do not have a standardised meaning

prescribed by GAAP, and so may not be comparable to similar financial information presented by other entities

Key metrics

Free cash flow

1

(CFEO + CFDA)

($186.9m)

Up $202.6m | FY23: ($389.6m)

R Y M A N H E A L T H C A R E|2024 Annual Shareholder Meeting7
Capital management

Note all figures are FY24 unless otherwise stated.

1Net interest-bearing debt, funding headroom and gearing are non-GAAP (Generally Accepted Accounting Principles) measures and do not have a standardised meaning prescribed by GAAP, and so may not be

comparable to similar financial information presented by other entities

2NTA per share is calculated as total equity less intangible assets and deferred tax asset, divided by shares on issue.

3Gearing is calculated as net interest-bearing debt to net interest-bearing debt plus total equity.

Net interest-bearing debt

1

$2.51b

Up $0.21b | FY23: $2.30b | 1H24: $2.47b

Gearing

1,3

(debt to debt plus equity)

36.2%

Up 3.1pp | FY23: 33.1%

Total equity

equity

$4.42b

Down $0.24b | FY23: $4.66b

NTA per share

2

: $6.015

Funding headroom

1

(including cash)

$507.5m

Down $69.7m | FY23: $577.2m

R Y M A N H E A L T H C A R E|2024 Annual Shareholder Meeting8
Keith Park main building under construction

Photo, 10 July 2024

Bert Newton main building under construction

Photo, 17 June 2024

Miriam Corban main building opened May 2024

Photo, 1 May 2024

James Wattie main building opened June 2024

Photo, 4 July 2024

Development progress

R Y M A N H E A L T H C A R E|2024 Annual Shareholder Meeting9
Sustainability progress

•We remain committed to our sustainability

journey and decarbonisingour operations

•Released our first Sustainability Report

inMay 2024

•In March 2024, our greenhouse gas

emissions targets were validated by the

Science Based Targets initiative (SBTi)

•Our first Climate-related Disclosures were

released in our FY24 Annual Report

R Y M A N H E A L T H C A R E|2024 Annual Shareholder Meeting10
Recognition during theyear

•Opened three new villages during FY24,

welcoming our first residents into

Northwood(Christchurch), Patrick Hogan

(Cambridge) and Bert Newton (Australia)

•NamedReader’s Digest Most Trusted Brand

in aged care and retirement living in

New Zealand for the tenth time

•Winner offour awards at the 2024 Asia Pacific

Eldercare Innovation Awards, including

Operator of the Year –Ageing in Place’

for the second year running

Miriam Corban Village resident, Keri.

R Y M A N H E A L T H C A R E|2024 Annual Shareholder Meeting11
Fit for the Future

R Y M A N H E A L T H C A R E|2024 Annual Shareholder Meeting12
Auditor

•External Auditor Independence Policy published

on 1 December 2023

•The rotation of audit firm will be tendered at least

every 10 years

•PwC recommended by the Board to be appointed

as auditorforthe financial yearcommencing

1 April 2024

R Y M A N H E A L T H C A R E|2024 Annual Shareholder Meeting13
Aged care funding under pressure

•Throughout the year, Ryman continued to advocate

for change-governments need to urgently address

the models to ensure sustainability of the sector

•Current aged care funding models not working in

New Zealand and Australia, leading to bed closures

and limited new builds in the face of growing demand

•TeWhataOra has provided only a 3.2% increase in

funding for the sector for the current year

R Y M A N H E A L T H C A R E|2024 Annual Shareholder Meeting14
FY25 outlook –unchanged fromfull year result

Cash flowWe continue to target positive free cash flow (representing the combination

of cash flow from existing operations and cash flow from development activity)

CapexWe expect to spend $700–820 million on capex , including:

•$600–700 million on development activity

•$100–120 million on existing operations

Completed build

rate

1

We expect to complete 850–950 retirement village units and aged care beds,

which includes:

•650 aged care beds and serviced apartments in four main buildings that will

be opened

•200-300 independent retirement village units

1Includesunits and beds reported at March 2024 as near complete

R Y M A N H E A L T H C A R E | 2024 Result Presentation15
Resolutions

Residents John and Bev at our Northwood Village.

15

R Y M A N H E A L T H C A R E|2024 Annual Shareholder Meeting16
Resolution 1

Auditor’s appointment and remuneration

That PwC Auckland is appointed as the auditor

of the Company and that the Board is authorised

to fix the auditor’s remuneration for the

ensuing year.

Artist’s impression of our Mulgrave Village.

R Y M A N H E A L T H C A R E|2024 Annual Shareholder Meeting17
Under NZX Listing Rule 2.7.1 a director appointed by

the Board must not hold office (without re-election)

past the next Annual Meeting following the director’s

appointment.

Ms Kate Munnings was appointed as a non-executive

director by the Board with effect from 1 November

2023. Ms Munnings accordingly retires and offers

herself for re-election at the 2024 Annual Meeting.

Ms Munnings is considered by the Board to be

independent.

Resolution 2

Re-election of Ms Kate Munnings

R Y M A N H E A L T H C A R E|2024 Annual Shareholder Meeting18
Under NZX Listing Rule 2.7.1 a director appointed by

the Board must not hold office (without re-election)

past the next Annual Meeting following the director’s

appointment.

Mr David Pitman was appointed as a non-executive

director by the Board with effect from 1 May 2024.

Mr Pitman accordingly retires and offers himself for

re-election at the 2024 Annual Meeting. Mr Pitman

is considered by the Board to be independent.

Resolution 3

Re-election of Mr David Pitman

R Y M A N H E A L T H C A R E | 2024 Result Presentation19
General business

Artist’s impression of our Bert Newton Village.

19

R Y M A N H E A L T H C A R E | 2024 Result Presentation20
Caregivers at our Anthony Wilding Village.

Thank you

20

R Y M A N H E A L T H C A R E|2024 Annual Shareholder Meeting21
Disclaimer

This presentation has been prepared by Ryman

Healthcare Limited and its group companies

("Ryman") for informational purposes.This

disclaimer applies to this document and the

verbal or written comments of any person

presenting it.

This presentation provides additional comments

on the full year result for the period to 31 March

2024 presented on 27 May 2024.It should be read

in conjunction with all other material which we

have released, or may release, to NZX from time

to time. That material is also available on our

website at rymanhealthcare.com.

Ryman disclaims and excludes all liability for any

loss suffered by any person as a result of the use

of or reliance on the information contained in,

or omitted from, this presentation, and makes

no representation or warranty as to the currency,

fairness, accuracy, completeness or reliability

of the information contained in this presentation,

in each case to the fullest extent permitted

by law.

Purpose of this presentation

This presentation isnot an offer of financial products, or a proposal or invitation to make

any such offer.It is not investment advice, or any otheradvice, or a recommendation

in relation to financial products, and does not take into account any person’s individual

circumstances or objectives. Every investor should make an independent assessment

of Ryman on the basis of expert financial advice.

Forward-looking statements

This presentation contains forward-looking statements and projections.These reflect our

current expectations, based on what we think are reasonable assumptions.However,

any of these forward-looking statements or projections may be materially different due

to a range of factors and risks. Ryman gives no warranty or representation as to our future

financial performance or any future matter.Actual results may differ materially from

those projected.Except as required by law or the NZX Listing Rules, Ryman undertakes

no obligation to update any forward-looking statements whether as a result of new

information, future events, or otherwise.

Non-GAAP information

A number offinancial measures used in this presentation are based on non-generally

accepted accountingprinciples (i.e.non-GAAP financial information).This includes,

in particular, our ‘underlying profit’ which Ryman has used for many years as a means

of showing our profit absent any unrealised valuation movements.We show our underlying

profit together with our reported profit based on NZ IFRS (a GAAP measure). You should

not considerany of these statements in isolation from, or in substitution for the information

provided in the Financial Statements for the 12 months ended 31March 2024.

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.

  • CVT — Comvita Limited: Comvita 2024 Annual Shareholders' Meeting
    2024-10-29

    NEXT SLIDE As you know, you will see some new faces on both the Board and management team today. On the Board, David Banfield has now left the company and Brett Hewlett has stepped into the CEO role in David’s place. Luke Bunt has rejoined the Board, formerly our Chair of Au…”

  • SCL — Scales Corporation Limited: 2024 Annual Shareholders' Meeting Presentations
    2024-06-05

    3 You may submit questions on each resolution being put to shareholders using the question process. For those of you who have joined us in person, those Shareholders who are entitled to vote and proxies who have discretion as to how they vote, should have received a Votin…”

  • 2CC — 2 Cheap Cars Group Limited: 2CC ASM Presentation
    2024-09-26

    1 280926 2CC ASM SCRIPT FINAL SLIDE 1 – 2CC 2023 ANNUAL SHAREHOLDERS’ MEETING Michael Stiassny Mōrena, good morning. My name is Michael Stiassny, Chairman of 2 Cheap Cars Group Limited. As it’s now 10.00am, I am pleased to open the 2 Cheap Cars Annual Shareholders’ Me…”